Vault-13

ORBIMED CAPITAL LLC

New York, NY · CIK 1157524 · 13F filing filed 2026-08-14

For Q2 2026 this manager filed a 13F notice: its holdings were reported by another manager.

Trades reported as a company insider since 1 Apr 2026

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2026-04-21 PRELUDE THERAPEUTICS INC Director · See footnotes PRLD Bought 2,815,315 $12.5m2.8m shares new